Literature DB >> 26259993

Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?

Bryan F Meyers1, Varun Puri2, Stephen R Broderick2, Pamela Samson2, Kathleen Keogan2, Traves D Crabtree2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26259993     DOI： 10.1016/j.jtcvs.2015.06.086

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  13 in total

Review 1.  Salvage surgery after high-dose radiotherapy.

Authors:  Annemie Van Breussegem; Jeroen M Hendriks; Patrick Lauwers; Paul E Van Schil
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 2.  Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Authors:  Drew Moghanaki; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2016-04

Review 3.  Treatment strategy and decision-making for elderly surgical candidates with early lung cancer.

Authors:  Jiro Okami
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

4.  Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.

Authors:  Pamela Samson; Kathleen Keogan; Traves Crabtree; Graham Colditz; Stephen Broderick; Varun Puri; Bryan Meyers
Journal:  Lung Cancer       Date:  2016-11-09       Impact factor: 5.705

5.  A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.

Authors:  Christopher Cao; Daniel Wang; Caroline Chung; David Tian; Andreas Rimner; James Huang; David R Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2018-09-15       Impact factor: 5.209

6.  Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer.

Authors:  Rhami Khorfan; Timothy J Kruser; Julia M Coughlin; Ankit Bharat; Karl Y Bilimoria; David D Odell
Journal:  Ann Thorac Surg       Date:  2020-03-05       Impact factor: 4.330

7.  Thoracic intervention and surgery to cure lung cancer.

Authors:  Tom Treasure
Journal:  J R Soc Med       Date:  2018-05-11       Impact factor: 5.344

8.  Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens.

Authors:  Shankar Siva; David Ball
Journal:  Oncologist       Date:  2016-03-16

Review 9.  Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy.

Authors:  David J Heineman; Johannes M Daniels; Wilhelmina H Schreurs
Journal:  Ther Adv Med Oncol       Date:  2017-08-02       Impact factor: 8.168

10.  Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience.

Authors:  Michael MacManus; Richard De Abreu Lourenco; Fiona Hegi-Johnson
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.